Effect of music therapy on behavioral and physiological neonatal outcomes: A systematic review and dose-response

Fatemeh Shahbazi1,2, Marzieh Fattahi-Darghlou1, Samad Moslehi3

  • 1Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.

Plos One
|January 8, 2025
PubMed

Insights

Music therapy significantly improves premature infant outcomes, including vital signs and sleep. Longer music exposure correlates with greater benefits, suggesting a causal link for enhanced neonatal care.

Area of Science:

  • Neonatal Medicine
  • Therapeutic Interventions
  • Evidence-Based Practice

Background:

  • Previous research confirms music therapy's efficacy for premature infants.
  • A knowledge gap exists regarding the optimal duration of music therapy for neonatal outcomes.

Purpose of the Study:

  • To determine the dose-response relationship between music therapy duration and neonatal outcomes.
  • To quantify the impact of increased music exposure on specific neonatal health indicators.

Main Methods:

  • A dose-response meta-analysis of randomized clinical trials was conducted.
  • Searches included PubMed, Scopus, Web of Science, and Cochrane Library databases.
  • A two-stage random effects model was utilized for analysis.

Main Results:

  • Each minute increase in music therapy decreased respiratory rate, pain score, and blood pressure, while improving behavioral and temperature scores.
  • Increased music exposure correlated with higher O2 saturation, heart rate, and sleep duration.
  • Analysis included 30 articles with 1855 participants.

Conclusions:

  • Music therapy positively impacts neonatal outcomes such as oxygen saturation, heart rate, respiratory rate, sleep, temperature, and blood pressure.
  • A significant dose-response relationship suggests a causal link between music therapy duration and improved neonatal health.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...